We are live on
!
Find out more
CM
Caption Management Portfolio holdings
AUM
$17.1B
1-Year Est. Return
70.99%
This Fund
S&P 500
This Quarter
Est. Return
+4.28%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$1.99B
AUM Growth
+$172M
(+9.5%)
Cap. Flow
+$156M
Cap. Flow
% of AUM
7.83%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
935
New
395
Increased
92
Reduced
99
Closed
294
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$8.42M |
| 2 |
Marathon Petroleum
MPC
|
+$5.47M |
| 3 |
Liberty Global Class C
LBTYK
|
+$5.39M |
| 4 |
O'Reilly Automotive
ORLY
|
+$5.32M |
| 5 |
Crocs
CROX
|
+$5.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$12.6M |
| 2 |
Tapestry
TPR
|
+$12M |
| 3 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$8.32M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$6.96M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
+$6.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.95% |
| 2 | Consumer Discretionary | 2.51% |
| 3 | Technology | 1.96% |
| 4 | Energy | 1.43% |
| 5 | Communication Services | 1.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
LiveRamp
RAMP
$2.3B
| $1.94M | 0.1% |
+40,000
| New | +$2.17M |
|
|
KYNB
252
Kyntra Bio
KYNB
$27.2M
| $1.92M | 0.1% |
1,704
+192
| +13% | +$210K |
|
253
Cheniere Energy
LNG
$55.2B
| $1.92M | 0.1% |
+28,000
| New | +$1.85M |
|
|
SC
254
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $1.92M | 0.1% |
+80,000
| New | +$1.78M |
|
255
CALL
Bausch Health
BHC
$2.58B
| $1.89M | 0.1% |
+75,000
| New | +$1.78M |
|
256
CALL
DuPont de Nemours
DD
$18.5B
| $1.88M | 0.09% |
19,917
+10,045
| +102% | +$1.2M |
|
|
257
PUT
DuPont de Nemours
DD
$18.5B
| $1.88M | 0.09% |
19,917
+10,045
| +102% | +$1.2M |
|
258
CALL
Upbound Group
UPBD
$1.13B
| $1.86M | 0.09% |
+70,000
| New | +$1.66M |
|
|
259
PUT
Upbound Group
UPBD
$1.13B
| $1.86M | 0.09% |
+70,000
| New | +$1.66M |
|
260
CALL
Century Communities
CCS
$1.91B
| $1.86M | 0.09% |
+70,000
| New | +$1.85M |
|
|
261
PUT
Century Communities
CCS
$1.91B
| $1.86M | 0.09% |
+70,000
| New | +$1.85M |
|
262
Union Pacific
UNP
$174B
| $1.86M | 0.09% |
+11,000
| New | +$1.88M |
|
263
AB InBev
BUD
$170B
| $1.86M | 0.09% |
+21,000
| New | +$1.8M |
|
264
Coty
COTY
$2.42B
| $1.85M | 0.09% |
+138,000
| New | +$1.7M |
|
|
SGI
265
CALL
Somnigroup International
SGI
$13.7B
| $1.83M | 0.09% |
100,000
-678,000
| -87% | -$10.9M |
|
266
CALL
Fox Class A
FOXA
$24.5B
| $1.83M | 0.09% |
+50,000
| New | +$1.84M |
|
|
267
PUT
Fox Class A
FOXA
$24.5B
| $1.83M | 0.09% |
+50,000
| New | +$1.84M |
|
268
CALL
CryoPort
CYRX
$761M
| $1.83M | 0.09% |
+100,000
| New | +$1.59M |
|
269
Knowles
KN
$3.13B
| $1.83M | 0.09% |
+100,000
| New | +$1.76M |
|
270
PUT
Southwest Airlines
LUV
$22B
| $1.78M | 0.09% |
35,000
-10,500
| -23% | -$544K |
|
|
271
Bausch Health
BHC
$2.58B
| $1.76M | 0.09% |
70,000
+25,000
| +56% | +$594K |
|
|
LK
272
DELISTED
Luckin Coffee Inc. American Depositary Shares
LK
| $1.76M | 0.09% |
+90,200
| New | +$1.67M |
|
|
TYPE
273
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $1.74M | 0.09% |
+103,250
| New | +$1.84M |
|
|
IMMU
274
DELISTED
Immunomedics Inc
IMMU
| $1.73M | 0.09% |
+125,000
| New | +$1.88M |
|
275
CALL
Diodes
DIOD
$3.78B
| $1.73M | 0.09% |
47,600
| – | – |
|
Similar funds
ASRS
PP
VMPIC
BCIM
BBA
FCM
AIMCA
Caption Management's Q2 2019 Portfolio in Review
As of Q2 2019, Caption Management held 935 positions worth $1.99B, up 9.5% from $1.81B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Caption Management deployed $156M of net new capital in Q2 2019, opening 395 new positions and adding to 92 existing holdings. Its largest new stake was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
By sector, the portfolio is most concentrated in Healthcare at 3% of assets, down from 3.9% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $12.6M trimmed.
- Caption Management's largest Q2 2019 buy was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
- Caption Management added most to Crocs in Q2 2019, an estimated $5.07M increase.
- Caption Management's biggest Q2 2019 reduction was Bristol-Myers Squibb, cutting an estimated $12.6M.
- Caption Management fully exited iShares MSCI Saudi Arabia ETF in Q2 2019, selling an estimated $8.32M.
- Caption Management's ten largest holdings make up 16% of its $1.99B portfolio in Q2 2019.
- Caption Management opened 395 new positions and closed 294 in Q2 2019.
- Caption Management's portfolio value rose 9.5% quarter-over-quarter to $1.99B.
Based on Caption Management's 13F filing for Q2 2019, filed 13 Aug 2019.